MedPath

Effectiveness of homoeopathic medicines in the management of Lumbar Spondylosis

Phase 2
Conditions
Health Condition 1: M47- Spondylosis
Registration Number
CTRI/2023/07/055470
Lead Sponsor
ATIONAL INSTITUTE OF HOMOEOPATHY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Subjects of age group 30 years to 70 years.

2. Patients presenting with clinical features and radiological findings of lumbar spondylosis.

3. Patients of all genders.

4. Patients willing to give informed consent to participate in the study.

Exclusion Criteria

1. Cases with congenital lumbar anomalies ( eg, Sacralization of fifth lumbar vertebrae, Spina bifida etc)

2. Patients unwilling to give consent for taking part in the study and regular follow ups.

3. Pregnant and lactating women.

4. Persons with terminal or life threatening illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oswestry Low Back Pain Disability QuestionnaireTimepoint: At baseline & at the end of 6th month
Secondary Outcome Measures
NameTimeMethod
ot applicableTimepoint: Not applicable
© Copyright 2025. All Rights Reserved by MedPath